Search | Page 13 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. SAA patient finds unrelated donor match in 2 weeks

    ... sergeant battling rare blood disease, awaiting marrow transplant Article Source:  ... between 18 and 44, and want to register as a bone marrow/stem cell donor can do it at join.bethematch.org/hope4sarge or ...

    Article last updated 03/21/2017 - 11:19am.

  2. Patient Trusts Her Instincts in Finding the Right Treatment

    ... me “If you were my mother I would prepare you for a stem cell transplant .”  When I first got to CTCA, I started on decitabine ...

    Patient Chronicle last updated 05/10/2018 - 11:01am.

  3. Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.

    ... Although hematopoietic stem cell transplantation (HSCT) with a conditioning regimen consisting of ...

    Research Article last updated 05/22/2017 - 10:32am.

  4. Stem Cell Transplantation: What Happens Behind the Scenes?

    ... take a patient all the way from first referral for a stem cell transplant right through the transplant itself. They’re the ...

    Interview last updated 01/18/2018 - 1:28pm.

  5. Treatment of low-risk myelodysplastic syndromes

    ... that they may induce responses. Finally, hematopoietic stem cell transplant is the curative option also for lower-risk MDS and timing ...

    Research Article last updated 01/26/2017 - 10:42am.

  6. Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the Europ

    ... conventional chemotherapy (CC) before hematopoietic stem cell transplantation (HSCT) in 209 patients with advanced myelodysplastic ...

    Research Article last updated 07/18/2016 - 11:22am.

  7. Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?

    ... syndromes (MDS) is allogeneic hematopoietic stem cell transplantation (alloSCT). As alloSCT confers both a short-term mortality ... is essential. Here, we review data on disease burden and transplant outcomes in MDS, describing which patients stand to benefit most ...

    Research Article last updated 04/29/2016 - 10:22am.

  8. High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

    ... high-dose cyclophosphamide without hematopoietic stem cell transplant to treat severe aplastic anemia (SAA) has been ...

    Research Article last updated 11/01/2016 - 1:49pm.

  9. San Diego Family Takes Action for Awareness

    ... he no longer needed transfusions. A search for a stem cell donor had been started prior to this treatment. Because David is ...

    Patient Chronicle last updated 04/26/2018 - 9:33am.

  10. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... not eligible for, or opted not to participate in allogenic stem cell transplantation h. Off all other treatments for MDS (including AZA ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.